Sunday feature: This Aussie company's share price is up 900% this year

Guest: Mesoblast founder Silviu Itescu Original air date: March 9, 2022 ASX-listed biotech Mesoblast is spoken about a lot on Fear and Greed due to its extremely volatile share price. This is largely tied to some big medical breakthroughs they've been working on for a long time.   Founder Silviu Itescu discusses the exhaustive and expensive process behind getting critical new drugs developed, tested and approved and the possible announcements that are coming. Update: Mesoblast's share price increased by 50% in just one day this week after the US FDA gave the green light to another one of its treatments. Find out more: https://fearandgreed.com.auSee omnystudio.com/listener for privacy information.